首页> 外文OA文献 >Probiotics and intestinal microflora of HIV-infected patients
【2h】

Probiotics and intestinal microflora of HIV-infected patients

机译:HIV感染患者的益生菌和肠道菌群

摘要

Background: HIV-1 infection results in marked immunologic insults, including pronounced CD4+ T-cell loss from gut lymphoid tissue, and structural damage to the intestinal mucosa following dysfunction of the gastrointestinal system, including compromised barrier function. Increased intestinal permeability and microbial translocation promote systemic immune activation, which is implicated in disease progression. While the development of highly active antiretroviral therapy (HAART) has been a major advancement in the treatment of HIV-1 infection, the need for novel complementary interventions to help repair intestinal structural and functional integrity remains unmet. Known properties of probiotics suggest that they may be useful tools in restoring normal intestinal flora. In this regard, the aim of the present study was to evaluate changes in microflora of the large intestine in chronic HIV infection and the possibility of correction by means of bacterial preparations (probiotics).
机译:背景:HIV-1感染导致明显的免疫损伤,包括肠道淋巴组织明显的CD4 + T细胞丢失,以及胃肠道系统功能异常(包括屏障功能受损)后肠粘膜结构受损。肠道通透性增加和微生物易位促进了全身免疫激活,这与疾病的进展有关。尽管开发高活性抗逆转录病毒疗法(HAART)在治疗HIV-1感染方面已取得重大进展,但仍未满足对新颖的辅助干预措施以帮助修复肠道结构和功能完整性的需求。益生菌的已知特性表明,它们可能是恢复正常肠道菌群的有用工具。在这方面,本研究的目的是评估慢性HIV感染中大肠微生物区系的变化以及通过细菌制剂(益生菌)进行矫正的可能性。

著录项

  • 作者

    Gorobchenko K.;

  • 作者单位
  • 年度 2016
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号